EquityFlow › Companies › Acesion Pharma

Acesion Pharma

Biotech · Copenhagen, DK

SK ion-channel inhibitors (AP31969) to treat atrial fibrillation

Funding history

DateRoundAmount
Oct 2023Series B
Copenhagen biotech Acesion Pharma raised a 45M EUR Series B led by Canaan and Alpha Wave to advance its atrial-fibrillation drug AP31969.
$48.6M

Investors

Alpha WaveCanaanGlobal BioAccess FundNovo Holdings

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →